Cue Biopharma Inc (CUE)
2.18
+0.13
(+6.34%)
USD |
NASDAQ |
May 07, 16:00
2.18
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Max Drawdown (5Y): 95.56% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 95.56% |
| March 31, 2024 | 94.40% |
| February 29, 2024 | 94.40% |
| January 31, 2024 | 94.40% |
| December 31, 2023 | 94.40% |
| November 30, 2023 | 94.40% |
| October 31, 2023 | 94.40% |
| September 30, 2023 | 92.74% |
| August 31, 2023 | 92.74% |
| July 31, 2023 | 92.74% |
| June 30, 2023 | 92.74% |
| May 31, 2023 | 92.74% |
| April 30, 2023 | 92.74% |
| March 31, 2023 | 92.74% |
| February 28, 2023 | 92.74% |
| January 31, 2023 | 92.74% |
| December 31, 2022 | 92.74% |
| November 30, 2022 | 92.74% |
| October 31, 2022 | 92.74% |
| September 30, 2022 | 92.74% |
| August 31, 2022 | 92.03% |
| July 31, 2022 | 92.03% |
| June 30, 2022 | 91.90% |
| May 31, 2022 | 89.26% |
| April 30, 2022 | 87.18% |
| Date | Value |
|---|---|
| March 31, 2022 | 85.65% |
| February 28, 2022 | 81.13% |
| January 31, 2022 | 76.47% |
| December 31, 2021 | 74.78% |
| November 30, 2021 | 74.78% |
| October 31, 2021 | 74.78% |
| September 30, 2021 | 74.78% |
| August 31, 2021 | 74.78% |
| July 31, 2021 | 74.78% |
| June 30, 2021 | 74.78% |
| May 31, 2021 | 74.78% |
| April 30, 2021 | 74.78% |
| March 31, 2021 | 74.78% |
| February 28, 2021 | 74.78% |
| January 31, 2021 | 74.78% |
| December 31, 2020 | 74.78% |
| November 30, 2020 | 74.78% |
| October 31, 2020 | 74.78% |
| September 30, 2020 | 74.78% |
| August 31, 2020 | 74.78% |
| July 31, 2020 | 74.78% |
| June 30, 2020 | 74.78% |
| May 31, 2020 | 74.78% |
| April 30, 2020 | 74.78% |
| March 31, 2020 | 74.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
74.78%
Minimum
May 2019
95.56%
Maximum
Apr 2024
82.61%
Average
74.78%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Precision BioSciences Inc | 98.55% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -49.95 |
| Beta (5Y) | 1.977 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.94% |
| Historical Sharpe Ratio (5Y) | -0.3629 |
| Historical Sortino (5Y) | -0.8564 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.64% |